STOCK TITAN

CRYOMASS TECHNOLOGIES INC - $CRYM STOCK NEWS

Welcome to our dedicated page for CRYOMASS TECHNOLOGIES news (Ticker: $CRYM), a resource for investors and traders seeking the latest updates and insights on CRYOMASS TECHNOLOGIES stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CRYOMASS TECHNOLOGIES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CRYOMASS TECHNOLOGIES's position in the market.

Rhea-AI Summary
CryoMass Technologies Inc. has reached an agreement with CRYM Co-Invest GP to sell up to five CryoSift Separatorâ„¢ Units for a total of up to US$6 million. The innovative financing structure provides growth capital to CryoMass while enabling wider deployment of the Company's processing technology. The funding arrangement will be non-dilutive to CryoMass shareholders, while providing a recurring revenue stream from processing fees charged to Clients. Access to capital has been an ongoing challenge for prospective Clients working in the cannabis industry due to federal prohibition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.5%
Tags
none
-
Rhea-AI Summary
CryoMass signs license agreement with RubberRock Inc. for large-scale cannabinoid production, guaranteeing at least $3 million in annual royalties. CryoMass aims to scale its disruptive technology and increase revenue potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
partnership
-
News
Rhea-AI Summary
CryoMass Technologies Inc. announces successful transition to commercial processing phase with its Trichome Separation Beta unit. The company has achieved a major milestone by designing and constructing an industrial-scale Beta system. CryoMass expects to receive scheduled payments from RedTape over the next 12 months and is engaged in discussions for market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.38%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.05%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.28%
Tags
management
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.07%
Tags
none
CRYOMASS TECHNOLOGIES INC

OTC:CRYM

CRYM Rankings

CRYM Stock Data

7.98M
158.66M
25.27%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Carson City